It is reported that EQT has proposed to acquire Qiagen (QGEN.US) for over $50 per share, and KKR is also participating in the bid.
EQT AB is engaged in advanced negotiations to acquire the European molecular diagnostics company Qiagen (QGEN.US), and has submitted a binding offer at over $50 per share.
Zhitong Finance APP has learned from informed sources that Swedish private equity firm EQT AB is in advanced talks to acquire European molecular diagnostics company Qiagen (QGEN.US) and has submitted a binding offer exceeding $50 per share. Sources also said that another private equity giant, KKR, is also participating in the bidding.
Driven by acquisition news, Qiagen’s US shares rose as much as 9.2% on Tuesday. The stock ultimately closed up 5.05% at $48.90, giving the company a market capitalization of over $10 billion. Qiagen is also listed in Frankfurt.
Sources stated that Qiagen’s board of directors will meet this week to make a decision on the potential deal. However, it remains uncertain whether the discussions will ultimately lead to Qiagen’s sale to EQT or another company. Representatives for Qiagen, EQT, and KKR all declined to comment.
If this acquisition is completed, it will become one of Europe’s largest healthcare deals this year and may also end years of takeover speculation surrounding Qiagen. Reports in January indicated that Qiagen was evaluating strategic options.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Nvidia is negotiating to invest hundreds of millions of dollars in Firmus
JPMorgan Asset Management includes bitcoin in long-term assumptions for the first time: 10-year annualized return expected at 10%, but 55% volatility remains a concern
JPMorgan Asset Management has included Bitcoin in its long-term capital market assumptions for the first time, forecasting that its returns over the next decade may outperform stocks, bonds, and gold. This is regarded as a milestone for Bitcoin's acceptance on Wall Street.
Crypto prices
More
